Reuters logo
BRIEF-Basilea says distribution agreement with Cardiome
2017年9月12日 / 凌晨5点20分 / 8 天前

BRIEF-Basilea says distribution agreement with Cardiome

Sept 12 (Reuters) - BASILEA PHARMACEUTICA AG:

* BASILEA ANNOUNCES DISTRIBUTION AGREEMENT WITH CARDIOME TO COMMERCIALIZE ANTIBIOTIC ZEVTERA/MABELIO (CEFTOBIPROLE) IN EUROPE AND ISRAEL

* ‍BASILEA WILL RECEIVE AN UPFRONT PAYMENT OF CHF 5 MILLION​

* CARDIOME GRANTED EXCLUSIVE LICENSE TO COMMERCIALIZE CEFTOBIPROLE IN MORE THAN 30 COUNTRIES IN EUROPE AND IN ISRAEL Source text for Eikon: Further company coverage: (Gdynia Newsroom)

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below